Identification
| Field of research | Weight research |
|---|---|
| Formula | C207H317N45O65 |
| Molecular weight | 4476 g/mol |
| CAS number | 2259884-03-0 |
| Also known as | IBI362, GTPL13924, IBI-362, GLXC-26803, compound 1 [US9938335B2], EX-A12490, LY3305677, LY-3305677 |
| PubChem | CID 167312357 |
Summary
Mazdutide is a dual agonist of the GLP-1 receptor and glucagon receptor.
From Wikipedia, available under CC BY-SA 4.0. Short description from Wikidata (CC0).
Published research
Titles are shown as published. Listing a paper is not an endorsement of its findings, and many papers on research peptides are laboratory or animal studies: the type of study is shown when PubMed records it.
- Once-Weekly Mazdutide in Chinese Adults with Obesity or OverweightRandomized Controlled TrialClinical Trial, Phase IIIMulticenter StudyJi L, Jiang H, Bi Y et al. · N Engl J Med, 2025 · PMID 40421736 · DOI
- Emerging pharmacotherapies for obesity: A systematic reviewSystematic ReviewKokkorakis M, Chakhtoura M, Rhayem C et al. · Pharmacol Rev, 2025 · PMID 39952695 · DOI
- Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysisSystematic ReviewNetwork Meta-AnalysisComparative StudyNong K, Shi Q, Xie X et al. · BMJ, 2026 · PMID 42419792 · DOI
- Mazdutide: First ApprovalReviewShirley M · Drugs, 2025 · PMID 41028652 · DOI
- Beyond weight loss: multisystem benefits of obesity medicationsReviewSavas M, Kuckuck S, Boon MR et al. · Lancet Diabetes Endocrinol, 2026 · PMID 42208956 · DOI
- Novel GLP-1-based Medications for Type 2 Diabetes and ObesityReviewSon JW, le Roux CW, Blüher M et al. · Endocr Rev, 2026 · PMID 41054801 · DOI
- Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trialsSystematic ReviewNetwork Meta-AnalysisResearch Support, Non-U.S. Gov'tXie Z, Zheng G, Liang Z et al. · Metabolism, 2024 · PMID 39305981 · DOI
- Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialRandomized Controlled TrialClinical Trial, Phase IIResearch Support, Non-U.S. Gov'tZhang B, Cheng Z, Chen J et al. · Diabetes Care, 2024 · PMID 37943529 · DOI
Top 8 of 51 results, by relevance. See all on PubMed.
Search query "Mazdutide"[Title/Abstract]
Data provenance
| Data | Source | Record |
|---|---|---|
| Chemical identity and structure | PubChem | CID 167312357 |
| Published literature | PubMed | Search on PubMed |
| Summary sentence | Wikipedia | Mazdutide |
Data retrieved 2026-10-08. See About for the sources. How the data is collected and checked: Methods.